United Arab Emirates Personalized Dietary Supplements Market Size & Outlook, 2025-2033
United Arab Emirates Personalized Dietary Supplements Market Insights
- According to Deep Market Insights analysis, the United Arab Emirates Personalized Dietary Supplements Market size was USD 654.68 Million in 2024 and is projected to reach USD 2302.35 Million by 2033.
- The United Arab Emirates market is projected to grow at a CAGR of 14.96% between 2026 and 2033.
- By segment, DNA Based Plans emerged as the largest Personalization Method in terms of market size in 2024.
- DNA Based Plans is anticipated to remain the most attractive Personalization Method segment, recording the fastest growth during the forecast period.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United Arab Emirates contributed 4.66% to the global Personalized Dietary Supplements Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Personalized Dietary Supplements Market.
- In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2033.
- Among Middle East and Africa markets, Nigeria is expected to post the fastest growth, reaching USD 337.12 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 654.68 Million |
| Market Size In 2033 | USD 2302.35 Million |
| Largest segment | DNA Based Plans |
| Units | Revenue in USD Million |
| CAGR | 14.96% (2025-2033) |
| Segmnetation Covered | |
| Personalization Method |
|
| Supplement Type |
|
| Delivery Format |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Arab Emirates Personalized Dietary Supplements Market Personalization Method 2025-2033 (USD Million)
| Personalization Method | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA Based Plans | XX.x | XX.x | XX.x | 353.99 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biomarker Analysis | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| App Driven Profiling | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Arab Emirates Personalized Dietary Supplements Market Supplement Type 2025-2033 (USD Million)
| Supplement Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitamins | XX.x | XX.x | XX.x | 262.2 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Minerals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Probiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Proteins | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Arab Emirates Personalized Dietary Supplements Market Delivery Format 2025-2033 (USD Million)
| Delivery Format | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsules | XX.x | XX.x | XX.x | 294.87 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gummies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.